90
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study

, , , , , , , , & show all
Pages 220-222 | Received 25 Jul 2017, Accepted 24 Aug 2017, Published online: 11 Sep 2017
 

Acknowledgements

The authors would like to thank Dr. Jennifer Engelmoer (TransPerfect Life Sciences) who provided medical writing services on behalf of San Raffaele Scientific Institute, and MSD Italia for supporting the study.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was funded by MSD Italia. The funder had no role in the analysis, interpretation or preparation of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.